The inhibitor that can selectively block p38 will prevent producing these destructive cytokines and ultimately alleviate the onset of inflammatory disease, such as RA, inflammatory bowel disease (IBD), psoriasis, stroke, myocardial ischemia, alzheimer disease, and respiratory disease (7, 8). The gene discussed is MAPK14; the disease is inflammatory bowel disease.